Found 72 matching trials
Investigation of Biomarker Response to SGLT2 Inhibition in Heart Failure N/A This is a 26-week, open label, single-arm prospective evaluation of the eff...
Show More Location
Belfast Health and Social Care Trust
Learn More & Join Trial
A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN PHASE2 This was a 28-week, open-label, multicenter, single-group Phase 2 explorato...
Show More Location
Travere Investigational Site
Learn More & Join Trial
PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care PHASE3 Background Acute Kidney Injury (AKI) is a potentially life-threatening cond...
Show More Learn More & Join Trial
Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial PHASE2 This study aims to provide essential mechanistic insights into natriuretic ...
Show More Location
Renal Physiology Laboratory
Learn More & Join Trial
Safety and Effectiveness of SGLT-2 Inhibitors in Patients With Heart Failure and Diabetes PHASE4 Patients with diabetes are at increased risk of developing heart failure (H...
Show More Location
Ninewells Hospital and Medical School
Learn More & Join Trial
SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease PHASE4 This study evaluates the metabolomics changes associated with dapagliflozin...
Show More Location
Virgen de la Victoria University Hospital. Endocrinology Department
Learn More & Join Trial
CardioRenal Effects of SGLT2 Inhibition in Kidney Transplant Recipients PHASE2 CREST-KT is a single-center, double-blinded, randomized trial of empagliflo...
Show More Location
Duke University Medical Center
Learn More & Join Trial
SGLT2 Inhibition and Left Ventricular Mass PHASE4 Patients with type 2 diabetes mellitus are exposed to an excessive heart fa...
Show More Location
Hannover Medical School
Learn More & Join Trial
SGLT2 Inhibitor Effects on Inflammation and Heart Disease in Obesity Pilot PHASE1 Obesity is associated with increased cardiometabolic disease risk due, in p...
Show More Location
Vanderbilt University Medical Center
Learn More & Join Trial
SGLT2 Inhibitors in Glomerular Hyperfiltration PHASE2 Glomerular hyperfiltration is a major risk factor for accelerated glomerula...
Show More Location
Multiple Locations
Learn More & Join Trial